Aerpio Pharmaceuticals Inc (ARPO)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

9987 CARVER ROAD CINCINNATI, OH 45242

Aerpio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on the development of novel therapeutics for vascular disorders with a concentration on diseases of the eye. Aerpio Pharmaceuticals offers its services in the United States.

Data as of 2020-11-22
Market Cap73.965 Million Shares Outstanding47.112 Million Avg 30-day Volume1.205 Million
P/E Ratio-15.7 Dividend Yield EPS-0.1
Price/Sales4.931 Price cash flow ratio Price free cash flow ratio-13.6
Book Value1.0 Price to Tangible Book1.56 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.138222
BETA1.96708 52-week High/Low1.92 / 0.42 Stddev0.265643
View SEC Filings from ARPO instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 33 22 50.0% 12 (0.79%) 4 (0.26%) 200.0%
13F shares: 17.41 Million 9.358 Million 86.03% 14.987 Million 7.16 Million 109.31%
% Ownership 41.3848 23.0569 79.49% 35.6265 17.6412 101.95%
New Positions: 16 6 166.67% 9
Increased Positions 7 2 250.0% 1 1 0.0%
Closed Positions 5 3 66.67% 1 3 -66.67%
Reduced Positions 2 6 -66.67% 1 1 0.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARPO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARPO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASTELEIN CALEY

  • Director
0 2020-06-24 1

PRELACK STEVEN

  • Director
0 2020-06-24 1

DUGEL PRAVIN

  • Director
0 2020-06-24 1

DALAL ANUPAM

  • Director
0 2020-06-24 1

COHEN CHERYL

  • Director
0 2020-06-24 1

PETERS KEVIN G. SEE REMARKS

  • Officer
0 2020-03-16 1

GARDNER JOSEPH H. PRESIDENT

  • Officer
  • Director
0 2020-03-16 1

MAREK REGINA VICE PRESIDENT OF FINANCE

  • Officer
0 2020-03-16 1

SATTER MUNEER A

  • Director
  • 10% Owner
0 2019-06-18 0

KHUONG CHAU QUANG

  • Director
  • 10% Owner
0 2019-06-18 0

ROGERS MICHAEL W SEE REMARKS

  • Officer
0 2019-05-14 0

HOFFMAN STEPHEN J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-05-14 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
4,049,804 2019-04-25 0

PAKOLA STEVE CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-15 0

SATTER MUNEER A

SATTER MUNEER A

  • Director
  • 10% Owner
22,172,068 2019-01-03 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

  • Director
  • 10% Owner
5,193,946 2018-06-28 0

DESAI DHAVAL CHIEF STRATEGY OFFICER

  • Officer
75,342 2018-05-09 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ISALY SAMUEL D

  • Director
  • 10% Owner
3,653,451 2017-03-15 0

WEISS PAUL M

  • Director
1,303,865 2017-03-15 0

MURPHY JAMES B SEE REMARKS

  • Officer
0 2017-03-15 0

KINLEY MATTHEW P SECRETARY, CFO

  • Officer
  • Director
  • 10% Owner
2,000,000 2008-04-01 0

PAPPAJOHN JOHN PRESIDENT

  • Officer
  • Director
  • 10% Owner
2,000,000 2008-04-01 0

VASSILIOU ARGYRIS

  • 10% Owner
1,000,000 2008-04-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments